ARCA bio up 36% on "positive" bucindolol data
Seeking Alpha,
Nano cap ARCA biopharma ( ABIO +35.7% ) is up on almost a 10x surge in volume in response to results from a Phase 2 clinical…
Nano cap ARCA biopharma ( ABIO +35.7% ) is up on almost a 10x surge in volume in response to results from a Phase 2 clinical…
Dr. Bristow - Photo Dr. Michael Bristow, President and CEO, WESTMINSTER, Colo., May 01, 2019 (GLOBE NEWSWIRE) -- (Nasdaq: ABIO)…
(GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to…
(GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to…
The lead author on the paper is Jonathan P. Piccini, MD, MHS, FACC, Director, Duke Center for Atrial Fibrillation, Duke…
(GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq:ABIO), a biopharmaceutical company applying a precision medicine approach to…
(GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to…